Offer - Urjas Oil for just ₹ 1 X
Cefoprox Cv is a prescription drug, available for use as Syrup, Tablet. The alternative uses of Cefoprox Cv have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Cefoprox Cv. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Cefoprox Cv as well, which are listed below. Normally, these side effects of Cefoprox Cv are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Cefoprox Cv has a Mild effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Cefoprox Cv has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Cefoprox Cv related warnings section.
Cefoprox Cv can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Cefoprox Cv in conditions like Jaundice. Some other conditions that can be affected by Cefoprox Cv are listed in the contraindications section below.
Drug reaction of Cefoprox Cv with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Cefoprox Cv, it is important to know that it is safe while driving, and is habit-forming.
Cefoprox Cv is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Cefoprox Cv safe for pregnant women?
Cefoprox CV has little to no side effects in pregnant women.
Is the use of Cefoprox Cv safe during breastfeeding?
Cefoprox CV can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Cefoprox Cv on the Kidneys?
There can be some harmful effects on your kidneys after taking Cefoprox CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cefoprox Cv on the Liver?
The liver can be affected by Cefoprox CV. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Cefoprox CV only after medical advice.
What is the effect of Cefoprox Cv on the Heart?
Very few cases of side effects of Cefoprox CV on the heart have been reported.
Cefoprox Cv should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Cefoprox Cv unless your doctor advises you to do so -
Is this Cefoprox Cv habit forming or addictive?
Forming a habit of Cefoprox Cv has not been reported.
Interaction between Food and Cefoprox Cv
Taking Cefoprox Cv with food does not cause any problems.
Interaction between Alcohol and Cefoprox Cv
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Cefoprox Cv.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311